Off-price retailers could thrive, BofA says, citing this bullish data point

Date:

November 14, 2024

BofA analysts reiterated buy ratings on Burlington Stores Inc., Ross Stores Inc. and TJX Cos. Thursday, ahead of the discount retailers’ coming third-quarter earnings, and said they expect all three to continue to attract core and trade-down consumers.

Source link

Roki Sasaki season is here, plus Scott Boras' big test

AI pioneer Francois Chollet leaves Google

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Off-price retailers could thrive, BofA says, citing this bullish data point

Recent posts

Tim Walz promises middle-class tax cuts and help for homebuyers in DNC speech

TSMC, Samsung reportedly consider building huge chip factories in UAE

Greenlight Capital’s clash with ex-staffer has hurt its business, lawsuit says

Urban Outfitters is departing from its ‘alternative sensibility’ to turn around namesake stores

Chipotle to speed up CFO transition after C-suite shakeup

Obesity drugs in kindergarten? Novo Nordisk GLP-1 drug works for kids as young as 6, study finds.

Bronfman boosts last-minute offer for National Amusements and Paramount, WSJ reports

Abercrombie & Fitch to see earnings ‘upside,’ but there’s potential margin pressure ahead: analyst

Oil prices on track for 4th straight weekly gain

What will OPEC+ decide on oil output? Here’s why it’s complicated.

Chegg says it’s doubling down on students while cutting nearly a quarter of its staff

Temu and Shein face U.S. crackdown as Biden administration cites abuse of trade loophole

Fed rate cuts may make ether more attractive after being left behind by bitcoin

Tommy Bahama maker says shoppers are still ‘more cautious than originally anticipated,’ but cites this improvement

5 stock-market takeaways as Biden sees ‘incredible pressure’ to step aside after debate

Related articles

Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS

Powell says Fed doesn’t need to hurry to cut interest rates

Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug

Republicans clinch control of House, setting stage for quicker action on extending tax cuts

This biotech’s stock could double if its treatment for major depressive disorder succeeds, says Mizuho

Cava is riding a strong wave, but the stock’s quadrupling in 2024 has analysts wary

Wells Fargo touches all-time high as analyst hikes price target to new level

Tesla is likely to thrive in a Trump administration. These are the ways these analysts see it happening.

Company

Follow us